Ignite Creation Date:
2024-05-06 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05703971
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2023-01-19
Brief Title:
Quaratusugene Ozeplasmid Reqorsa and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Sponsor:
Genprex Inc
Organization:
Genprex Inc
Organization Data
Organization:
Genprex Inc
Class:
INDUSTRY
Study ID:
ONC-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genprex Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None